BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8692530)

  • 21. Plasma bone-specific alkaline phosphatase as an indicator of osteoblastic activity.
    Leung KS; Fung KP; Sher AH; Li CK; Lee KM
    J Bone Joint Surg Br; 1993 Mar; 75(2):288-92. PubMed ID: 8444951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does serum alkaline phosphatase level really indicate the prognosis in patients with osteosarcoma? A meta-analysis.
    Gu R; Sun Y
    J Cancer Res Ther; 2018 Jun; 14(Supplement):S468-S472. PubMed ID: 29970708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic importance of alkaline phosphatase activity in serum from dogs with appendicular osteosarcoma: 75 cases (1990-1996).
    Ehrhart N; Dernell WS; Hoffmann WE; Weigel RM; Powers BE; Withrow SJ
    J Am Vet Med Assoc; 1998 Oct; 213(7):1002-6. PubMed ID: 9776998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and validation of a pretreatment prognostic index to predict death and lung metastases in extremity osteosarcoma.
    Wang B; Tu J; Yin J; Zou C; Wang J; Huang G; Xie X; Shen J
    Oncotarget; 2015 Nov; 6(35):38348-59. PubMed ID: 26435480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Role of alkaline phosphatase Regan isoenzyme in prognosis of patients with osteosarcoma].
    Tucci A; Saviano C; Del Prete S
    Medicina (Firenze); 1990; 10(2):158-60. PubMed ID: 2273951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intraoperative radiation therapy for osteosarcoma.
    Yamamuro T; Kotoura Y
    Cancer Treat Res; 1993; 62():177-83. PubMed ID: 8096731
    [No Abstract]   [Full Text] [Related]  

  • 27. Automated and semiautomated analysis of rat alkaline phosphatase isoenzymes.
    Hoffmann WE; Everds N; Pignatello M; Solter PF
    Toxicol Pathol; 1994; 22(6):633-8. PubMed ID: 7732280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical usefulness of bone alkaline phosphatase in osteoporosis.
    Kyd PA; Vooght KD; Kerkhoff F; Thomas E; Fairney A
    Ann Clin Biochem; 1998 Nov; 35 ( Pt 6)():717-25. PubMed ID: 9838984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High level of beta-hCG simulating pregnancy in recurrent osteosarcoma: case report and review of literature.
    Leidinger B; Bielack S; Koehler G; Vieth V; Winkelmann W; Gosheger G
    J Cancer Res Clin Oncol; 2004 Jun; 130(6):357-61. PubMed ID: 15042358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-421 is a diagnostic and prognostic marker in patients with osteosarcoma.
    Zhou S; Wang B; Hu J; Zhou Y; Jiang M; Wu M; Qin L; Yang X
    Tumour Biol; 2016 Jul; 37(7):9001-7. PubMed ID: 26758431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glycosylation differences contribute to distinct catalytic properties among bone alkaline phosphatase isoforms.
    Halling Linder C; Narisawa S; Millán JL; Magnusson P
    Bone; 2009 Nov; 45(5):987-93. PubMed ID: 19631305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone-origin alkaline phosphatase in plasma by wheat-germ lectin methods in bone disease.
    Rosalki SB
    Clin Chim Acta; 1994 May; 226(2):143-50. PubMed ID: 7923809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical utility of biochemical bone turnover markers in children and adolescents with osteosarcoma.
    Ambroszkiewicz J; Gajewska J; Klepacka T; Chełchowska M; Laskowska-Klita T; Woźniak W
    Adv Med Sci; 2010; 55(2):266-72. PubMed ID: 21084254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isoforms of bone alkaline phosphatase: characterization and origin in human trabecular and cortical bone.
    Magnusson P; Larsson L; Magnusson M; Davie MW; Sharp CA
    J Bone Miner Res; 1999 Nov; 14(11):1926-33. PubMed ID: 10571693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Biochemical bone turnover markers in patients with conventional and nonconventional osteosarcoma].
    Ambroszkiewicz J; Gajewska J; Klepacka T; Bilska K; Woźniak W; Laskowska-Klita T
    Pol Merkur Lekarski; 2006 Oct; 21(124):330-4. PubMed ID: 17205770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measurement of bone alkaline phosphatase and relative study with osteosarcoma.
    Yang Z; Huo Y; Sun G; Li J; Li X
    Front Med China; 2007 Feb; 1(1):54-7. PubMed ID: 24557618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The age dependent levels of serum ALP isoenzymes and the diagnostic significance of corticosteroid-induced ALP during long-term glucocorticoid treatment.
    Syakalima M; Takiguchi M; Yasuda J; Hashimoto A
    J Vet Med Sci; 1997 Oct; 59(10):905-9. PubMed ID: 9362039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of chronic renal failure on bone turnover and bone alkaline phosphatase isoforms.
    Magnusson P; Sharp CA; Magnusson M; Risteli J; Davie MW; Larsson L
    Kidney Int; 2001 Jul; 60(1):257-65. PubMed ID: 11422759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma proteome predicts chemotherapy response in osteosarcoma patients.
    Li Y; Dang TA; Shen J; Hicks J; Chintagumpala M; Lau CC; Man TK
    Oncol Rep; 2011 Feb; 25(2):303-14. PubMed ID: 21165584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoclonal antibodies against tissue-nonspecific alkaline phosphatase. Report of the ISOBM TD9 workshop.
    Magnusson P; Arlestig L; Paus E; Di Mauro S; Testa MP; Stigbrand T; Farley JR; Nustad K; Millán JL
    Tumour Biol; 2002; 23(4):228-48. PubMed ID: 12499779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.